ABUS vs DKNG · P/E 5.4, rev $6.2M vs rev $4.77B
Arbutus Biopharma Corp (ABUS) versus DraftKings Inc (DKNG) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
DraftKings Inc (DKNG) is a gambling company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported DKNG revenue for 2024-12-31 was $4.77B. Net income was -$507.3M. Revenue was up 30.1% from 2023-12-31 to 2024-12-31. DKNG currently screens at market cap $20.96B.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. DKNG currently screens at market cap $20.96B.
Not investment advice. Open the ABUS and DKNG stock pages for the full models.
Not investment advice.